Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.

The global Neuromodulation and Neurostimulation Pain Management Devices market size is projected to grow from US$ 2215 million in 2024 to US$ 3265 million in 2030; it is expected to grow at a CAGR of 6.7% from 2024 to 2030.

ReportPrime's newest research report, the “Neuromodulation and Neurostimulation Pain Management Devices Industry Forecast” looks at past sales and reviews total world Neuromodulation and Neurostimulation Pain Management Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuromodulation and Neurostimulation Pain Management Devices sales for 2023 through 2029. With Neuromodulation and Neurostimulation Pain Management Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation and Neurostimulation Pain Management Devices industry.

This Insight Report provides a comprehensive analysis of the global Neuromodulation and Neurostimulation Pain Management Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuromodulation and Neurostimulation Pain Management Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuromodulation and Neurostimulation Pain Management Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation and Neurostimulation Pain Management Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation and Neurostimulation Pain Management Devices.

Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by:

• Increase in geriatric population
• Rise in prevalence of chronic pain
• Surge in awareness among people toward pain management devices
• Improved R&D investment to develop innovative products
• Launch of innovative products

In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation and Neurostimulation Pain Management Devices market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Spinal Cord Stimulators
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices

Segmentation by Application:

• Neuropathic Pain
• Cancer Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Medtronic Plc
• Boston Scientific Corporation
• Pfizer Inc. (Hospira Inc.)
• Johnson & Johnson (Codman And Shurtleff, Inc.)
• Stryker Corporation
• Kimberly-Clark Corporation (Baylis Medical)
• Colfax Corporation (Djo Global Llc)
• Abbott Laboratories
• B Braun Melsungen Ag
• Baxter International Inc.